Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Nykode Therapeutics AS (VACBF) Q3 2024 Earnings
VACBF
21
Aug
Confirmed
Q4 2023
Q2 2024
Q3 2024
-0.05
-0.04
-0.03
-0.02
Details
Expected EPS
-0.049687
Actual EPS
-0.022747
Surprise EPS
0.03
Surprise Percent
+54.22%
Description
Nykode Therapeutics AS (VACBF) has reported earnings of -0.022747 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login